National quantification of EMHLS is an annual exercise conducted by NMS under the direct supervision of MoH, and the exercise is intended to provide all public sector players/stakeholder in the health sector with feedback about facility needs in accordance with the NMS Act Cap 207 that states in par...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate...
The Ministry of Health (MoH) Department of Pharmaceuticals and Natural Medicines (DPNM) coordinated the first integrated quantification process for Essential Medicines and Health Supplies (EMHS) for the public and PNFP sector for Financial Years 2023/24 - 2025/26.�Quantification is a core component...
In June 2010, the Ugandan Ministry of Health (MOH) with support from the United States Agency for International Development (USAID)-funded Securing Ugandans�� Right to Essential Medicines (SURE) Program, collected data for the 2010 Pharmaceutical Sector Report. This report presents the findings of t...
Drug use, drug use disorders and related health conditions are major public health concerns. According to WHO��s latest estimates for 2015, psychoactive drug use is responsible for more than 450 000 deaths per year. The drug-attributable disease burden accounts for about 1.5% of the global burden of...
The Ministry of Health (MOH), in collaboration with the U.S. Agency for International Development (USAID), the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), the USAID Global Health Supply Chain-Procurement and Supply Management (GHSC-PSM) project, and the USAID Uganda Health...
The National Drug Authority Strategic Plan 2020/2021-2024/2025 builds on the gains achieved in the previous period and also focuses on consolidating efficiency and effectiveness in drug regulation, as provided for within the mandate of the Drug Authority. This strategic plan has been aligned to the...
The World Health Organization (WHO), the United Nations Children��s Fund (UNICEF) and many other organizations are involved in the procurement of pharmaceutical products. In particular, the supply of pharmaceutical products used in the treatment of human immunodeficiency virus/acquired immunodeficie...
The thirty-ninth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 6 to 10 November 2017. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting by welcoming all par...
The NMS Act Cap 207 states that the corporation shall advise the Ministry of Health, Ministry of Finance, Planning and Economic Development, Ministry of Local Government and National Drug Authority on essential issues relating to the state of the Corporation and its future development as well as to...
This manual was developed by the Pharmacy Division, Ministry of Health, in collaboration with the Securing Ugandans�� Right to Essential Medicines (SURE) Program with assistance from health workers representing all levels of care. The purpose of this manual is to provide health workers with a refere...
About 275 million people worldwide, which is roughly 5.6 per cent of the global population aged 15-64 years, used drugs at least once during 2016. Some 31 million of people who use drugs suffer from drug use disorders, meaning that their drug use is harmful to the point where they may need treatment...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making. This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate s...